Plasma exchange as a cost-effective option for treating Guillain–Barré syndrome-Reference-Cited by-同舟云学术

Plasma exchange as a cost-effective option for treating Guillain–Barré syndrome

Published:2016-08-20 Issue:1 Volume:10 Page:76-77
ISSN:1756-2864
Container-title:Therapeutic Advances in Neurological Disorders
language:en
Short-container-title:Ther Adv Neurol Disord

Author:

Buenz Eric J¹,Parry Gareth J²,Ranta Annemarei³

Affiliation:

1. Nelson Marlborough Institute of Technology, Nelson, New Zealand

2. Nelson Marlborough Institute of Technology, 322 Hardy Street, Nelson, 7010, New Zealand, Capital & Coast District Health Board, Wellington, New Zealand

3. Capital & Coast District Health Board, Wellington, New Zealand University of Otago, Wellington, New Zealand

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology,Pharmacology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1756285616659978

Reference7 articles.

1. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study

2. Cost-minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis

3. Intravenous immunoglobulin for Guillain-Barré syndrome

4. Resource implications of a national health target: The New Zealand experience of a Shorter Stays in Emergency Departments target

5. Plasma exchange for Guillain-Barré syndrome

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low‐cost alternatives for the management of Guillain‐Barré syndrome in low‐ and middle‐income countries;World Medical & Health Policy;2021-09-16

2. Guillain-Barré syndrome;The Lancet;2021-03

3. Single-needle: an effective alternative to dual-needle peripheral access in therapeutic plasma exchange;Journal of Clinical Apheresis;2018-11-02